Follow the people · Insider
SVF Pauling (Cayman) Ltd
SVF Pauling (Cayman) Ltd files insider transactions with the SEC as a 10% owner of Relay Therapeutics (RLAY). We hold 1 disclosed purchase or sale filed since 21 July 2020, 1 of them in the last 90 days.
- Files forRLAY
- Disclosed buys and sells1 in all, 1 in the last 90 days
- Last disclosure28 August 2026
Positions held
1 post we hold — a term names its own dates; a run of filings only says when they filed- Filed 20 July 2020 — 25 August 202610% owner · Relay Therapeutics (RLAY)3 Form 4 lines · source: SEC Form 4
Everything they disclosed
3 entries, newest first — one per disclosure report, one per Form 4 line- ▼ sold on the open market 6,000,000 shares of Relay TherapeuticsSEC Form 428 August 2026Common Stock · traded 25 August 2026 · filed 28 August 2026
- converted 99,088,292 shares of Relay Therapeutics (a derivative holding)SEC Form 421 July 2020Series C Convertible Preferred Stock · traded 20 July 2020 · filed 21 July 2020
- converted 27,904,963 shares of Relay TherapeuticsSEC Form 421 July 2020Common Stock · traded 20 July 2020 · filed 21 July 2020
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.